All Posts: cancer
208 Articles
- GUMC Stories
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells…
February 2, 2024
- GUMC Stories
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that…
January 18, 2024
- GUMC Stories
Ruesch Center Symposium Focuses on Early-Onset GI Cancer
With an emphasis on early-onset gastrointestinal cancer, the 14th Annual Ruesch Center Symposium brought together nearly 300 health care providers, researchers, advocates,…
November 22, 2023
- GUMC Stories
2023 Men’s Event Returns in Support of Cancer Research at Georgetown Lombardi
More than 150 men gathered for the 23rd Annual Men’s Event to help raise money and awareness for cancer research in support of Georgetown University’s Lombardi Comprehensive…
November 21, 2023
- News Release
Computer Models Fill Critical Knowledge Gaps To Help Reduce Cancer Disparities
Reducing health disparities in incidence and mortality for major types of cancers can be aided by sophisticated computer modeling efforts, according to new, wide-ranging…
November 8, 2023
- GUMC Stories
Raskin Discusses Cancer Diagnosis and Cura Personalis at Annual Kovach Lecture
On September 26, U.S. Rep. Jamie Raskin came to Georgetown to discuss his cancer experiences and thank his treating physician, MedStar Georgetown University Hospital hematologist…
September 29, 2023
- GUMC Stories
Routine Lung Screening Spots Aggressive Cancer Early, Allows Successful Treatment
The detection of an aggressive form of lung cancer in a patient treated by experts at Georgetown University’s Lombardi Comprehensive Cancer Center demonstrates the importance…
August 24, 2023
- News Release
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to…
July 17, 2023
- News Release
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, Georgetown Lombardi researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the…
June 20, 2023
- News Release
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other…
June 15, 2023